Clinicians rely on standard protocols and reference ranges when assessing patients’ clinical conditions. However, we know even subtle changes to baseline vital signs that are within “normal limits” can provide early indication of potential issues. That’s exactly what happened at a skilled nursing facility during the Covid-19 pandemic.
In October 2022, an XK300 sensor flagged changes in a resident’s heart and respiratory rates. Although the readings were still considered within normal limits, the clinical team at this facility had seen the sensor successfully detect infections before, so they kept a close eye on her.
The next day, the resident’s daughter called with news: she had just tested positive for Covid-19, and had recently visited her mother. Sure enough, the resident tested positive for Covid-19 and began developing symptoms a day later.
The XK300 sensor detected signs of Covid-19 24 hours before diagnosis, and 48 hours before the first symptom. As the disease spread to other residents, the XK300 sensors in each room detected similar patterns of changes in baseline vital signs, helping care teams identify new infections and begin treatment as quickly as possible.
“When it comes to a resident’s health, subtle changes can speak volumes,” says Sam Yang, Co-founder, Xandar Kardian, Inc. “With early detection of baseline vital changes, the XK300 gives clinicians the information they need to assess and intervene early.”
Meet the XK300
The XK300 uses radar monitoring to track heart rate, respiratory rate, motion and presence. In fact, it is the first commercially available medical device cleared by the FDA to do so. Our radar can sense through blankets, clothing, furniture and even drywall to detect micro vibrations from the body — safely. Discover how it can make a difference for your residents and staff.Learn more